Functioning and Symptom Remission in Women with Postpartum Depression Treated with Antidepressants

2.50
Hdl Handle:
http://hdl.handle.net/10755/160435
Type:
Presentation
Title:
Functioning and Symptom Remission in Women with Postpartum Depression Treated with Antidepressants
Abstract:
Functioning and Symptom Remission in Women with Postpartum Depression Treated with Antidepressants
Conference Sponsor:Midwest Nursing Research Society
Conference Year:2003
Author:Phillips, Amanda
Contact Address:SON, 1907 Buttonwood Road, Louisville, KY, 40222, USA
Depression during the perinatal period is a major public health concern. Approximately 13% of women experience postpartum depression (PPD), with up to half of these women having episodes that last seven months or longer. The most significant factor in the duration of the depression is delay in receiving treatment. PPD has a profound and negative impact on role functioning including global functioning, personal relationships and satisfaction with the baby. Research has demonstrated that symptoms of PPD improve with antidepressant treatment. However, we do not know how role functioning improves with antidepressant treatment, or how role functioning is related to symptom remission. Therefore, the purpose of this study was to describe the role functioning of women with PPD being treated with antidepressants. A second purpose was to determine the relationship between measures of depression symptoms and functioning. A Stress and Coping Framework was used to guide the study. The study was a secondary data analysis from a R01 Randomized Clinical Trial funded by NIMH (Katherine Wisner, PI; PPD; Nortriptyline vs. Sertaline). The goal of Dr. Wisner's study (N=200) was to compare rates of response and patient compliance to two antidepressants, with data collected before and after eight weeks of treatment. Using descriptive statistics and Pearson's Correlations, results of analysis for this study are preliminary (N=61), but indicate that both depression symptoms and role functioning improved after treatment. However, the changes in symptom measures were not correlated with changes in role functioning. Clinical treatment guidelines for PPD should advocate measurement of functioning as well as symptom remission. AN: MN030043
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Midwest Nursing Research Society

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleFunctioning and Symptom Remission in Women with Postpartum Depression Treated with Antidepressantsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/160435-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Functioning and Symptom Remission in Women with Postpartum Depression Treated with Antidepressants </td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Midwest Nursing Research Society</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2003</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Phillips, Amanda</td></tr><tr class="item-address"><td class="label">Contact Address:</td><td class="value">SON, 1907 Buttonwood Road, Louisville, KY, 40222, USA</td></tr><tr><td colspan="2" class="item-abstract">Depression during the perinatal period is a major public health concern. Approximately 13% of women experience postpartum depression (PPD), with up to half of these women having episodes that last seven months or longer. The most significant factor in the duration of the depression is delay in receiving treatment. PPD has a profound and negative impact on role functioning including global functioning, personal relationships and satisfaction with the baby. Research has demonstrated that symptoms of PPD improve with antidepressant treatment. However, we do not know how role functioning improves with antidepressant treatment, or how role functioning is related to symptom remission. Therefore, the purpose of this study was to describe the role functioning of women with PPD being treated with antidepressants. A second purpose was to determine the relationship between measures of depression symptoms and functioning. A Stress and Coping Framework was used to guide the study. The study was a secondary data analysis from a R01 Randomized Clinical Trial funded by NIMH (Katherine Wisner, PI; PPD; Nortriptyline vs. Sertaline). The goal of Dr. Wisner's study (N=200) was to compare rates of response and patient compliance to two antidepressants, with data collected before and after eight weeks of treatment. Using descriptive statistics and Pearson's Correlations, results of analysis for this study are preliminary (N=61), but indicate that both depression symptoms and role functioning improved after treatment. However, the changes in symptom measures were not correlated with changes in role functioning. Clinical treatment guidelines for PPD should advocate measurement of functioning as well as symptom remission. AN: MN030043</td></tr></table>en_GB
dc.date.available2011-10-26T22:56:26Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T22:56:26Z-
dc.description.sponsorshipMidwest Nursing Research Societyen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.